The healthcare sector is experiencing a significant upward trend, largely driven by continued positive sentiment following Moderna and Merck's announcement of a successful Phase 3 trial for their personalized mRNA-based cancer vaccine. This news, reported earlier in the week, has been described as a major breakthrough in cancer treatment and has fueled investor enthusiasm across the biotechnology and pharmaceutical industries. The positive momentum from this announcement appears to be the primary catalyst for the sector's strong performance, overshadowing broader market movements.